Recommendation ID
DG30/1
Question

NICE considered that further research is needed to determine whether faecal haemoglobin levels are influenced by age, sex and medicines that increase the risk of gastrointestinal bleeding. It noted that these data could be used to further develop risk scores that include variables such as age, sex and symptoms to help determine pre-test probability. The data could also be combined with faecal haemoglobin concentration to refine management after the use of faecal immunochemical tests in primary care.

Any explanatory notes
(if applicable)

N/A


Source guidance details

Comes from guidance
Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care
Number
DG30
Date issued
July 2017

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/07/2017